Cargando…
Evaluating kratom alkaloids using PHASE
Kratom is a botanical substance that is marketed and promoted in the US for pharmaceutical opioid indications despite having no US Food and Drug Administration approved uses. Kratom contains over forty alkaloids including two partial agonists at the mu opioid receptor, mitragynine and 7-hydroxymitra...
Autores principales: | Ellis, Christopher R., Racz, Rebecca, Kruhlak, Naomi L., Kim, Marlene T., Zakharov, Alexey V., Southall, Noel, Hawkins, Edward G., Burkhart, Keith, Strauss, David G., Stavitskaya, Lidiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7053747/ https://www.ncbi.nlm.nih.gov/pubmed/32126112 http://dx.doi.org/10.1371/journal.pone.0229646 |
Ejemplares similares
-
Assessing the Structural and Pharmacological Similarity of Newly Identified Drugs of Abuse to Controlled Substances Using Public Health Assessment via Structural Evaluation
por: Ellis, Christopher R., et al.
Publicado: (2019) -
Predicting opioid receptor binding affinity of pharmacologically unclassified designer substances using molecular docking
por: Ellis, Christopher R., et al.
Publicado: (2018) -
Editorial: The Pharmacology of Kratom and Its Alkaloids
por: Grundmann, Oliver, et al.
Publicado: (2022) -
Kratom Alkaloids: Interactions With Enzymes, Receptors, and Cellular Barriers
por: Hanapi, Nur Aziah, et al.
Publicado: (2021) -
Effects of Nutrient Fertility on Growth and Alkaloidal Content in Mitragyna speciosa (Kratom)
por: Zhang, Mengzi, et al.
Publicado: (2020)